Research and Markets: Global Ergot Alkaloids (Migraine) Report 2014

DUBLIN–(BUSINESS WIRE)–

Research and Markets (http://www.researchandmarkets.com/research/kwzrcj/ergot_alkaloids) has announced the addition of the “Ergot Alkaloids (Migraine) – Forecast and Market Analysis to 2023″ report to their offering.

The Ergot Alkaloids were the very first anti-migraine-specific therapy class to reach the market. The first pure ergot alkaloid was isolated in 1920, but only in 1925 was ergotamine used to successfully treat a case of severe and intractable migraine via subcutaneous injection (Rothlin, 1955; Stoll, 1965). Over the following decades, ergotamine’s use as a migraine treatment was investigated by various researchers and its potent vasoconstriction properties reinforced the belief that migraine had a vascular origin.

Scope

  • Overview of Migraine, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
  • Detailed information on Ergot Alkaloids including product description, safety and efficacy profiles as well as a SWOT analysis.
  • Sales forecast for Ergot Alkaloids for the top two countries from 2012 to 2023.
  • Sales information covered for the US and Japan.

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Disease Overview

3.1 Etiology and Pathophysiology

  • Etiology
  • Pathophysiology
  • Prognosis

3.2 Symptoms

  • Premonitory Phase
  • Aura Phase
  • Headache Phase
  • Postdrome Phase

4 Disease Management

  • Acute Migraine Treatment
  • Preventive Migraine Treatment

5 Competitive Assessment

6 Ergot Alkaloids

  • Efficacy
  • Safety
  • SWOT Analysis
  • Forecast

7 Appendix

For more information visit http://www.researchandmarkets.com/research/kwzrcj/ergot_alkaloids

  • Personal Investing Ideas & Strategies
  • Health
  • Ergot Alkaloids
  • migraine treatment
Contact:

Research and Markets
Laura Wood, Senior Manager.
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System

Did you find this useful? More Info: JustNoHeadache.com

  • DON’T  LEAVE  EMPTY-HANDED !!!

    Download your FREE Report on Headache

    slide12t

    Just a sneak peek…

    • Guide to cluster headache
    • Why do you get a headache?
    • Headache and migraine pain relief through hypnotherapy
    • Can stress cause severe headache?
    • Caffeine: the culprit behind our migraines
    • Menopause and headaches
    • Sinusitis: how serious is it?
    Download It Completely FREE

    Just Insert Your Name and email

    We will also send you a Complimentary copy of our Headache Newsletter. Our newsletter subscription has the latest information on Headache and Migraine treatments.

    We respect your privacy. We will NEVER sell, rent or share your email address. That’s more than a policy, it’s our personal guarantee!

  • Now you can have the Latest News on Headache

    hedac02-220

    Worried about Headache and Migraine? You can have now information about the latest treatments and medical research. All this and more in our Headache Newsletter.slide11t

    Try it for four weeks. We will even send you FREE our bonus health e-book with your trial subscription.

    All for just ONE PENNY

    Get the latest information – don’t be left in the dark on your condition.

     CLICK HERE 

    Check our special offer: Subscribe to one newsletter, get another newsletter for FREE!